|
[Related PubMed/MEDLINE] Total Number of Papers: 23
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2014 |
Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo. |
CAH, HPLC, NC, SV, SW |
2 |
2010 |
High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma. |
--- |
3 |
2009 |
Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan. |
NB, SNP |
4 |
2007 |
Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification. |
--- |
5 |
2007 |
Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan. |
CR, NB, UF |
6 |
2006 |
Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan. |
--- |
7 |
2006 |
Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients. |
NB |
8 |
2005 |
Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening. |
CD, CRC, FOB |
9 |
2005 |
Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study. |
NB |
10 |
2002 |
Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities. |
--- |
11 |
2000 |
The correlation of stage and pathology of prostate cancer in Japan. |
GUOSG, PSA |
12 |
1999 |
Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants. |
CI, Dis1Del1p, Tris1Del1p |
13 |
1999 |
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. |
LOH, NBL |
14 |
1998 |
An infant with neuroblastoma and MYCN amplification found through mass screening. |
--- |
15 |
1997 |
Laparoscopic resection of mass-screened adrenal neuroblastoma in an 8-month-old infant. |
NB |
16 |
1996 |
[The mass screening for prostate cancer and the age eligibility. Gunma Urological Oncology Study Group]. |
DRE |
17 |
1995 |
Screening for neuroblastoma: a 9-year birth cohort-based study in Niigata, Japan. |
HPLC, VMA |
18 |
1994 |
Clinical significance of prostate specific antigen for early stage prostate cancer detection. |
PCa, PSA, PSAV |
19 |
1994 |
How to deal with advanced cases of neuroblastoma detected by mass screening: a report from the Pediatric Oncology Study Group of the Kyushu area of Japan. |
--- |
20 |
1994 |
One hundred neuroblastomas detected through a mass screening system in Japan. |
UH, UP |
21 |
1994 |
[The significance of six sextant biopsy for prostate cancer]. |
BPH, DRE, OPC, Pca, REC, TRUS |
22 |
1993 |
Mass screening for prostate cancer and the bias relating to survival rate. |
PCa |
23 |
1990 |
Problems of mass screening for neuroblastoma: analysis of false-negative cases. |
DMs |
|